surmount-1 tirzepatide non-diabetic obesity trial Effect of in trial. (BMI: body mass index; CI: Tirzepatide for the treatment of
Description
Share your complete supplement list with your healthcare provider for accurate interpretation
All medications within these trials are once weekly subcutaneously-administered injections
Before starting any medication, you will be evaluated by a licensed provider who will review your medical history, current medications, and health goals
The tirzepatide for weight loss guide details the expected outcomes at each dose tier based on the SURMOUNT trial data
